메뉴 건너뛰기
Nature Reviews Endocrinology
Volumn 9, Issue 10, 2013, Pages 568-570
Cancer: ADT and acute kidney injury - Causal or casual relationship?
Author keywords

[No Author keywords available]
Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;
EID: 84884596956     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.167     Document Type: Article
Times cited : (3)
References (10)
  • 1
    • 78649823503 scopus 로고    scopus 로고
    • An update on androgen deprivation therapy for prostate cancer
    • Sharifi, N., Gulley, J. L. & Dahut, W. L. An update on androgen deprivation therapy for prostate cancer. Endocr. Relat. Cancer 17, R305-R315 (.2010
    • (2010) Endocr. Relat. Cancer , vol.17
    • Sharifi, N.1    Gulley, J.L.2    Dahut, W.L.3
  • 2
    • 84880283328 scopus 로고    scopus 로고
    • Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer
    • Lapi, F. et al. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA 310, 289-296 (.2013
    • (2013) JAMA , vol.310 , pp. 289-296
    • Lapi, F.1
  • 3
    • 64049106282 scopus 로고    scopus 로고
    • Metabolic complications of androgen deprivation therapy for prostate cancer
    • Saylor, P. J. & Smith, M. R. Metabolic complications of androgen deprivation therapy for prostate cancer. J. Urol. 181, 1998-2006 (.2009
    • (2009) J. Urol , vol.181 , pp. 1998-2006
    • Saylor, P.J.1    Smith, M.R.2
  • 4
    • 33749058933 scopus 로고    scopus 로고
    • Diabetes and cardiovascular disease during androgen deprivation for prostate cancer
    • Keating, N. L., O'Malley, A. J. & Smith, M. R. Diabetes and cardiovascular disease during androgen deprivation for prostate cancer. J. Clin. Oncol. 24, 4448-4456 (.2006
    • (2006) J. Clin. Oncol , vol.24 , pp. 4448-4456
    • Keating, N.L.1    O'Malley, A.J.2    Smith, M.R.3
  • 5
    • 79951932137 scopus 로고    scopus 로고
    • Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer
    • Alibhai, S. M. et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J. Clin. Oncol. 28, 5038-5045 (.2010
    • (2010) J. Clin. Oncol , vol.28 , pp. 5038-5045
    • Alibhai, S.M.1
  • 6
    • 4344590998 scopus 로고    scopus 로고
    • Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: Effects on bone mineral density and body composition
    • Smith, M. R. et al. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: Effects on bone mineral density and body composition. J. Clin. Oncol. 22, 2546-2553 (.2004
    • (2004) J. Clin. Oncol , vol.22 , pp. 2546-2553
    • Smith, M.R.1
  • 7
    • 11844252588 scopus 로고    scopus 로고
    • Risk of fracture after androgen deprivation for prostate cancer
    • Shahinian, V. B., Kuo, Y. F., Freeman, J. L. & Goodwin, J. S. Risk of fracture after androgen deprivation for prostate cancer. N. Engl. J. Med. 352, 154-164 (.2005
    • (2005) N. Engl. J. Med , Issue.352 , pp. 154-164
    • Shahinian, V.B.1    Kuo, Y.F.2    Freeman, J.L.3    Goodwin, J.S.4
  • 8
    • 29144517438 scopus 로고    scopus 로고
    • Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer
    • Smith, M. R. et al. Risk of clinical fractures after gonadotropin- releasing hormone agonist therapy for prostate cancer. J. Urol. 175, 136-139 (.2006
    • (2006) J. Urol , vol.175 , pp. 136-139
    • Smith, M.R.1
  • 10
    • 56549084704 scopus 로고    scopus 로고
    • Bisphosphonate nephrotoxicity
    • Perazella, M. A. & Markowitz, G. S. Bisphosphonate nephrotoxicity. Kidney Int. 74, 1385-1393 (.2008
    • (2008) Kidney Int , vol.74 , pp. 1385-1393
    • Perazella, M.A.1    Markowitz, G.S.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.